The economic costs of jail-based methadone maintenance treatment

References

• Schmitt J, Warner K, Gupta S. The high budgetary cost of incarceration. Washington, DC: Center for Economic and Policy Research; 2010.
   Google Scholar
• Henrichson C, Delaney R. The price of prisons: what incarceration costs taxpayers. Fed Sent’g Rep. 2012;25:68. doi:10.1525/fsr.2012.25.1.68.
   Google Scholar
• Mai C, Subramanian R. The price of prisons: examining state spending trends, 2010–2015. New York, NY: Vera Institute of Justice; 2017.
   Google Scholar
• Wish ED, Johnson BD. The impact of substance abuse on criminal careers. Criminal Careers and “Career Criminals. 1986;2:52–88.
   Google Scholar
• Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system. JAMA. 2009;301(2):183–90. doi:10.1001/jama.2008.976.
   PubMed Web of Science ®Google Scholar
• Karberg JC, James DJ. Substance dependence, abuse, and treatment of jail inmates, 2002. Washington, DC: US Department of Justice, Office of Justice Programs, Bureau of Justice Statistics Washington; 2005.
   Google Scholar
• Anglin MD, Perrochet B. Drug use and crime: A historical review of research conducted by the UCLA Drug Abuse Research Center. Subst Use Misuse. 1998;33(9):1871–914. doi:10.3109/10826089809059325.
   PubMed Web of Science ®Google Scholar
• Brauer S. Inside a killer drug epidemic: a look at America’s opioi crisis. The New York Times. 2017.
   Google Scholar
• Bronson J, Stroop J, Zimmer S, Berzofsky M. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007-2009. Bureau of Justice Statistics; 2017 June. https://wwwbjsgov/content/pub/pdf/dudaspji0709pdf.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-46, HHS Publication No(SMA) 13-4795. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2013.
   Google Scholar
• Furst R. One in five Hennepin County jail inmates used or abused opioids, study found. Star Tribune. 2018.
   Google Scholar
• Dumont DM, Brockmann B, Dickman S, Alexander N, Rich JD. Public health and the epidemic of incarceration. Annu Rev Public Health. 2012;33:325–39. doi:10.1146/annurev-publhealth-031811-124614.
   PubMed Web of Science ®Google Scholar
• Cartwright WS. Cost–benefit analysis of drug treatment services: review of the literature†. J Ment Health Policy Econ. 2000;3(1):11–26.
   PubMedGoogle Scholar
• French MT, Drummond M. A research agenda for economic evaluation of substance abuse services. J Subst Abuse Treat. 2005;29(2):125–37. doi:10.1016/j.jsat.2005.05.009.
   PubMed Web of Science ®Google Scholar
• Doran CM. Economic evaluation of interventions to treat opiate dependence: a review of the evidence. Pharmacoeconomics. 2008;26(5):371–93.
   PubMed Web of Science ®Google Scholar
• French MT, Popovici I, Tapsell L. The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement. J Subst Abuse Treat. 2008;35(4):462–69. doi:10.1016/j.jsat.2007.12.008.
   PubMed Web of Science ®Google Scholar
• Horn BP, Crandall C, Forcehimes A, French MT, Bogenschutz M. Benefit-cost analysis of SBIRT interventions for substance using patients in emergency departments. J Subst Abuse Treat. 2017;79:6–11. doi:10.1016/j.jsat.2017.05.003.
   PubMed Web of Science ®Google Scholar
• Zarkin GA, Dunlap LJ, Homsi G. The substance abuse services cost analysis program (SASCAP): a new method for estimating drug treatment services costs. Eval Program Plann. 2004;27(1):35–43. doi:10.1016/j.evalprogplan.2003.09.002.
   Web of Science ®Google Scholar
• McCollister KE, French MT, Inciardi JA, Butzin CA, Martin SS, Hooper RM. Post-release substance abuse treatment for criminal offenders: A cost-effectiveness analysis. J Quant Criminol. 2003;19(4):389–407. doi:10.1023/B:JOQC.0000005441.49529.61.
   Web of Science ®Google Scholar
• McCollister KE, French MT, Prendergast M, Wexler H, Sacks S, Hall E. Is in‐prison treatment enough? A cost‐effectiveness analysis of prison‐based treatment and aftercare services for substance‐abusing offenders. Law Policy. 2003;25(1):63–82. doi:10.1111/1467-9930.00140.
   Google Scholar
• McCollister KE, French MT, Prendergast ML, Hall E, Sacks S. Long-term cost effectiveness of addiction treatment for criminal offenders. Justice Q. 2004;21(3):659–79. doi:10.1080/07418820400095941.
   Web of Science ®Google Scholar
• Collins PA, Cooper JA, Horn B, Stohr MK, Walsh A, Bostaph L, Baker ET. The cost of substance abuse: the use of administrative data to investigate treatment benefits in a rural mountain state. West Criminol Rev. 2010;11(3):13.
   Google Scholar
• Williams T. Opioid users are filling jails. Why don’t jails treat them? New York Times. 2017.
   Google Scholar
• Bruce RD, Schleifer RA. Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention. Int J Drug Policy. 2008;19(1):17–23. doi:10.1016/j.drugpo.2007.11.019.
   PubMed Web of Science ®Google Scholar
• Rich JD, Boutwell AE, Shield DC, Key RG, McKenzie M, Clarke JG, Friedmann, PD. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005;82(3):411–19. doi:10.1093/jurban/jti072.
   PubMed Web of Science ®Google Scholar
• McMillan GP, Lapham S, Lackey M. The effect of a jail methadone maintenance therapy (MMT) program on inmate recidivism. Addiction. 2008;103(12):2017–23. doi:10.1111/j.1360-0443.2008.02361.x.
   PubMed Web of Science ®Google Scholar
• Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105(1):83–88. doi:10.1016/j.drugalcdep.2009.06.015.
   PubMed Web of Science ®Google Scholar
• Matusow H, Dickman SL, Rich JD, Fong C, Dumont DM, Hardin C, Marlowe, D, Rosenblum, A. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat. 2013;44(5):473–80. doi:10.1016/j.jsat.2012.10.004.
   PubMed Web of Science ®Google Scholar
• Warren E, Viney R, Shearer J, Shanahan M, Wodak A, Dolan K. Value for money in drug treatment: economic evaluation of prison methadone. Drug Alcohol Depend. 2006;84(2):160–66. doi:10.1016/j.drugalcdep.2006.01.010.
   PubMed Web of Science ®Google Scholar
• Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska, A, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015;386(9991):350–59. doi:10.1016/S0140-6736(14)62338-2.
   PubMed Web of Science ®Google Scholar
• Westerberg VS, McCrady BS, Owens M, Guerin P. Community-based methadone maintenance in a large detention center is associated with decreases in inmate recidivism. J Subst Abuse Treat. 2016;70:1–6. doi:10.1016/j.jsat.2016.07.007.
   PubMed Web of Science ®Google Scholar
• French MT, Roebuck MC, McLellan AT. Cost estimation when time and resources are limited: the brief DATCAP. J Subst Abuse Treat. 2004;27(3):187–93. doi:10.1016/j.jsat.2004.07.001.
   PubMed Web of Science ®Google Scholar
• Roebuck MC, French MT, McLellan AT. DATStats: results from 85 studies using the drug abuse treatment cost analysis program (DATCAP). J Subst Abuse Treat. 2003;25(1):51–57.
   PubMed Web of Science ®Google Scholar
• French MT, Dunlap LJ, Zarkin GA, McGeary KA, McLellan AT. A structured instrument for estimating the economic cost of drug abuse treatment: the Drug Abuse Treatment Cost Analysis Program (DATCAP). J Subst Abuse Treat. 1997;14(5):445–55.
   PubMed Web of Science ®Google Scholar
• McCollister KE, French MT. The cost of drug abuse treatment in criminal justice settings. In: Leukefeld CC, Tims F, Farabee D, editors. Treatment of drug offenders: policies and issues. New York, NY: Springer Publishing Company; 2002. p. 22–37.
   Google Scholar
• Zhang SX, Roberts REL, McCollister KE. An economic analysis of the in-prison therapeutic community model on prison management costs. J Crim Justice. 2009;37(4):388–95. doi:10.1016/j.jcrimjus.2009.06.006.
   Web of Science ®Google Scholar
• Barnett PG. The cost‐effectiveness of methadone maintenance as a health care intervention. Addiction. 1999;94(4):479–88.
   PubMed Web of Science ®Google Scholar
• Zarkin GA, Dunlap LJ. Implications of managed care for methadone treatment: findings from five case studies in New York state. J Subst Abuse Treat. 1999;17(1):25–35.
   PubMed Web of Science ®Google Scholar
• Dunlap LJ, Zarkin GA, Cowell AJ. Examining variation in treatment costs: A cost function for outpatient methadone treatment programs. Health Serv Res. 2008;43(3):931–50. doi:10.1111/j.1475-6773.2007.00799.x.
   PubMed Web of Science ®Google Scholar
• Jones ES, Moore BA, Sindelar JL, O’Connor PG, Schottenfeld RS, Fiellin DA. Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients. Drug Alcohol Depend. 2009;99(1):132–40. doi:10.1016/j.drugalcdep.2008.07.013.
   PubMed Web of Science ®Google Scholar
• Doran CM, Shanahan M, Mattick RP, Ali R, White J, Bell J. Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug Alcohol Depend. 2003;71(3):295–302.
   PubMed Web of Science ®Google Scholar
• Curtis LA. Unit costs of health and social care 2008; Kent, UK: University of Kent; 2008.
   Google Scholar
• Martínez-Raga J, Saiz FG, Pascual C, Casado MA, Torres FJS. Suboxone®(buprenorphine/naloxone) as an agonist opioid treatment in Spain: a budgetary impact analysis. Eur Addict Res. 2010;16(1):31–42. doi:10.1159/000259614.
   PubMed Web of Science ®Google Scholar
• Moore TJ, Ritter A, Caulkins JP. The costs and consequences of three policy options for reducing heroin dependency. Drug Alcohol Rev. 2007;26(4):369–78. doi:10.1080/09595230701373883.
   PubMed Web of Science ®Google Scholar
• Vanagas G, Padaiga Ž, Bagdonas E. Cost-utility analysis of methadone maintenance treatment in Lithuania. Medicina. 2010;46(4):286–92.
   PubMed Web of Science ®Google Scholar
• Beaston-Blaakman A, Shepard D, Horgan C, Ritter G. Organizational and client determinants of cost in outpatient substance abuse treatment. J Ment Health Policy Econ. 2007;10(1):3–13.
   PubMed Web of Science ®Google Scholar
• Horn BP, Barragan GN, Fore C, Bonham CA. A cost comparison of travel models and behavioural telemedicine for rural, Native American populations in New Mexico. J Telemed Telecare. 2016;22(1):47–55. doi:10.1177/1357633X15587171.
   PubMed Web of Science ®Google Scholar
• Yilmaz SK, Horn BP, Fore C, Bonham CA. Increased size, increased efficiency? An economic cost analysis of an expanding, multistate behavioral telehealth intervention. J Telemed Telecare. 2018;1:1357633X18774181.
   Web of Science ®Google Scholar